Why the study?
Guidance was needed on how to interpret, analyze, and use the Kansas City Cardiomyopathy Questionnaire in clinical trials, clinical practice, and population health to improve patient-centered heart failure care.
This review provides guidance on interpreting and analyzing the KCCQ in clinical trials and practice to improve patient-centered heart failure care.
No takes yet. Share an insight, caveat, or question.
Supports KCCQ monitoring in HF care; leaves open prospective trials to guide therapy.
Spertus et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: